Skip To Main Content
Simon John on Muck Rack

Simon John

As seen in: Daily Mail, Frontiers, Irish Veterinary Journal, Blasting News, Cell Press, DZone, Schweizer Radio und Fernsehen, History Today, PRovoke Media, Beobachter and

Get in touch with Simon

Contact Simon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Resident tissue macrophages maintain intraocular pressure homeostasis

|
By Katy C. Liu, Aleksander Grimsrud, María Suárez Verified, Darren Schuman, Michael L. De Ieso, Megan Kuhn, Ruth Kelly, Rose Mathew, Joan Kalnitsky, Matthias Mack, Gerasimos Anagnostopoulos, Florent Ginhoux, Violet Bupp-Chickering, Revathi Balasubramanian, Simon John, W. Daniel Stamer, Daniel Saban
| Cell Press Verified
Keywords glaucoma macrophages monocytes mononuclear phagocytes ontogeny intraocular pressure trabecular meshwork Get full text access Log in, subscribe or purchase for full access. References 1. Quigley, H.A. ∙ Broman, A.T. The number of people with glaucoma worldwide in 2010 and 2020 Br. J. Ophthalmol. 2006; 90:262-267 2. Heijl, A. ∙ Leske, M.C. ∙ Bengtsson, B.
Open in Who Shared Issue with article?

Security Hardening for Community Linux: Best Practices + Tools

|
By Simon John
| tuxcare.com
Go straight to an AI summary of this blog post instead Key Takeaways AlmaLinux and Rocky Linux provide a strong foundation, but require hardening to close security gaps and enforce consistent configurations. Effective hardening includes least-privilege access, kernel and network tuning, and automated controls to prevent configuration drift. TuxCare Enterprise Support provides FIPS-validated modules, FIPS-compliant patches, and extended security updates to keep systems stable and enterprise-ready.
Open in Who Shared Issue with article?

UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinoma.

|
By Simon John, Nicola Jane, Jahangeer Mahmood
| gla.ac.uk
Hussain, S. et al. (2025) UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinoma. Oncologist, 30(10), oyaf220. (doi: 10.1093/oncolo/oyaf220) (PMID:41165670) (PMCID:PMC12574332) Text 371241.pdf - Published Version Available under License Creative Commons Attribution Non-commercial.
Open in Who Shared Issue with article?
See all 25 licensed articles (26 Total)